CN105456533A - Traditional Chinese medicine formula for treating ankylosing spondylitis - Google Patents

Traditional Chinese medicine formula for treating ankylosing spondylitis Download PDF

Info

Publication number
CN105456533A
CN105456533A CN201510993085.2A CN201510993085A CN105456533A CN 105456533 A CN105456533 A CN 105456533A CN 201510993085 A CN201510993085 A CN 201510993085A CN 105456533 A CN105456533 A CN 105456533A
Authority
CN
China
Prior art keywords
parts
chinese medicine
ankylosing spondylitis
traditional chinese
herba
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
CN201510993085.2A
Other languages
Chinese (zh)
Inventor
王璐
许璟
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Qingdao Changanda Pharmaceutical Co Ltd
Original Assignee
Qingdao Changanda Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Qingdao Changanda Pharmaceutical Co Ltd filed Critical Qingdao Changanda Pharmaceutical Co Ltd
Priority to CN201510993085.2A priority Critical patent/CN105456533A/en
Publication of CN105456533A publication Critical patent/CN105456533A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/25Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258Panax (ginseng)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/13Coniferophyta (gymnosperms)
    • A61K36/15Pinaceae (Pine family), e.g. pine or cedar
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/29Berberidaceae (Barberry family), e.g. barberry, cohosh or mayapple
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/80Scrophulariaceae (Figwort family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/85Verbenaceae (Verbena family)

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention discloses a traditional Chinese medicine formula for treating ankylosing spondylitis. The traditional Chinese medicine is prepared from the following traditional Chinese medicine raw materials in parts by weight: 25-36 parts of solidago decurrens, 12-29 parts of folium ginseng, 10-23 parts of climbing groundsel herb, 9-18 parts of Ermu Ning, 3-9 parts of radix berberidis, 5-13 parts of elecampane, 4-16 parts of cortex pseudolaricis, 3-9 parts of callicarpa macrophylla and 2-8 parts of Indian adenosma herb. With the compatibility of the medicines, the traditional Chinese medicine composition disclosed by the invention has the functions of clearing heat and removing toxin, resolving dampness and dredging collaterals, activating blood and reliving pain, nourishing liver and kidney and strengthening tendons and nourishing governor vessel and also adjusts blood circulation and improves human immunity; and moreover, the curative effect on ankylosing spondylitis is exact and remarkable, the effective rate is high, and the ankylosing spondylitis does not relapse easily after healing.

Description

A kind of Chinese medicine formula for the treatment of ankylosing spondylitis
Technical field
The present invention relates to a kind of Chinese medicine formula for the treatment of ankylosing spondylitis.
Background technology
Ankylosing spondylitis (ankylosingspondility, AS) is that one is apt to occur in 10-40 year, major determinant axis joint, and can involve the chronic progressive external immune disease of joint, periphery, internal organs and other tissue in various degree.Primary disease sickness rate is high, and national survey prevalence is 0.3%, incidence of occult, and the course of disease is very long, late period rigid spine, joint deformity, causes deformity in various degree, affects the life quality of patient.
AS belongs to Chinese medicine arthromyodynia, rheumatism involving the bone, muscular rheumatism category.From the clinical characters of primary disease, show different with general arthromyodynia, or can called after " ridge numbness ".The generation of primary disease take deficiency of both the liver and kidney as endogenous cause of ill, and wind, cold, wet, hot all heresies are inducement, this to modern medicine to the morbidity of AS and heredity, body constitution, environment, infection etc. multifactor relevant closely.Along with development and change, the deficiency and excess differentiation of pathological changes, can show as Liver and kidney, deficiency of qi and blood, governor vessel loses supports, and wind, cold, wet, heat, expectorant, the stasis of blood are pented up, and clonic spasm of the muscle bone damages, and cause the complicated syndrome that deficiency syndrome mingling with excess syndrome, cold and heat are held concurrently mutually.
The Basic disease cause pathogenesis of primary disease is that ferritic is weak, innate deficiency, Liver and kidney blood and essence asthenia, and wind and cold is wet deeply invades kidney and superintend and direct, cold-damp or can strongly fragrant and heat-transformation, gos deep into bone joint, spinal column.Liver and kidney asthenia of essence and blood, clonic spasm of the muscle weak bone and heresy are stayed and does not go, gradually causing phlegm-turbidity and blood stasis blood hinders in body, and cause the touching difficulty of disease eventually more, facing card is divided into kidney to superintend and direct virtual loss, anemofrigid-damp arthralgia, and the hepatic and renal YIN deficiency, damp-heat arthralgia hinder, and caused by liver and kidney deficiency, blockage of phlegm and blood stasis 3 type opinion are controlled.
Western medical treatment ankylosing spondylitis commonly uses sulfasalazine, methotrexate, nonsteroidal anti-inflammatory analgetic as Ying Taiqing, diclofenac etc., the pain symptom of patient can be controlled, alleviate the mental pressure of patient, but the disease process of ankylosing spondylitis can not be suppressed, easily recur after drug withdrawal.
Summary of the invention
Technical problem to be solved by this invention is: provide a kind of Chinese medicine for the treatment of ankylosing spondylitis.
For solving the problems of the technologies described above, the technical solution used in the present invention is:
A kind of Chinese medicine formula for the treatment of ankylosing spondylitis provided by the invention, be made up of the raw material of Chinese medicine of following weight portion: Herba Solidaginis 25-36 part, Folium Ginseng 12-29 part, Herba Hieracii Umbellati 10-23 part, two female peaceful 9-18 parts, Radix Berberidis 3-9 part, Radix Inulae 5-13 part, Cortex Pseudolaricis 4-16 part, Folium Callicarpae Macrophyllae 3-9 part, Herba Adenosmae 2-8 part.
Preferably, Chinese medicine provided by the invention is made up of the raw material of Chinese medicine of following weight portion: Herba Solidaginis 30 parts, Folium Ginseng 22 parts, Herba Hieracii Umbellati 18 parts, two peaceful 13 parts of mothers, Radix Berberidis 6 parts, Radix Inulae 9 parts, Cortex Pseudolaricis 11 parts, Folium Callicarpae Macrophyllae 6 parts, Herba Adenosmae 5 parts.
Usage and dosage: above-mentioned raw materials, is simmered in water after boiling with high heat 30 minutes after 10 minutes with warm water soaking again, taking liquid 150 milliliters, then add water and two to decoct, filter after twice medicinal liquid mixing, take at twice.Twice daily, one after each meal.
The course for the treatment of: 15 days be a course for the treatment of, the 2-5 course for the treatment of need be taken.
Clinical verification:
Statistics patient 100 example, man 50 example, female 50 example, oral Chinese medicine of the present invention, added up after 4 courses for the treatment of, clinical recovery 88 example, effective 6 examples, effective 4 examples, invalid 2 examples, total effective rate reaches 98%, shows this invention treatment by Chinese herbs Be very effective, reaches clinical treatment object, and over the course for the treatment of, have no obvious adverse reaction.
Beneficial effect of the present invention:
The all medicine compatibilities of Chinese medicine composition of the present invention have heat-clearing and toxic substances removing, removing dampness dredging collateral, promoting blood circulation and stopping pain, nourishing the liver and kidney, strong muscle support the effect of superintending and directing, regulate blood circulation, improve body immunity, treatment ankylosing spondylitis determined curative effect, significantly, effective percentage is high, not easily recurs more.
Detailed description of the invention
Embodiment 1
A kind of Chinese medicine formula for the treatment of ankylosing spondylitis that the present embodiment provides, is made up of the raw material of Chinese medicine of following weight portion: Herba Solidaginis 30 parts, Folium Ginseng 22 parts, Herba Hieracii Umbellati 18 parts, two peaceful 13 parts of mothers, Radix Berberidis 6 parts, Radix Inulae 9 parts, Cortex Pseudolaricis 11 parts, Folium Callicarpae Macrophyllae 6 parts, Herba Adenosmae 5 parts.
Model case:
1. Zhao, female, 45 years old, because of lower back stiff pain companion two lower limb paroxysmal pain fiber crops more than 3 years, diagnosis: ankylosing spondylitis, alleviates by symptom after 3 courses for the treatment of of treatment by Chinese herbs of the present invention, can walk and stand, transference cure after 2 courses for the treatment of of continual cure, functional rehabilitation.Follow up a case by regular visits to and do not recur for 2 years.
2. Wang, man, 63 years old, the stiff pain of patient's neck lower back, x-ray display cervical curvature straightened, diagnosis: ankylosing spondylitis.Obviously alleviate by waist and sacrum pain after 1 course for the treatment of of treatment by Chinese herbs of the present invention, movablely to take a turn for the better, continue to strengthen treatment 1 the pain course for the treatment of and stiff sense disappears, spinal column activity recovers normal and fully recovers.Follow up a case by regular visits to and have no recurrence in 1 year.

Claims (2)

1. treat the Chinese medicine formula of ankylosing spondylitis for one kind, it is characterized in that, be made up of the raw material of Chinese medicine of following weight portion: Herba Solidaginis 25-36 part, Folium Ginseng 12-29 part, Herba Hieracii Umbellati 10-23 part, two female peaceful 9-18 parts, Radix Berberidis 3-9 part, Radix Inulae 5-13 part, Cortex Pseudolaricis 4-16 part, Folium Callicarpae Macrophyllae 3-9 part, Herba Adenosmae 2-8 part.
2. Chinese medicine according to claim 1, is characterized in that, is made up of the raw material of Chinese medicine of following weight portion: Herba Solidaginis 30 parts, Folium Ginseng 22 parts, Herba Hieracii Umbellati 18 parts, two peaceful 13 parts of mothers, Radix Berberidis 6 parts, Radix Inulae 9 parts, Cortex Pseudolaricis 11 parts, Folium Callicarpae Macrophyllae 6 parts, Herba Adenosmae 5 parts.
CN201510993085.2A 2015-12-28 2015-12-28 Traditional Chinese medicine formula for treating ankylosing spondylitis Withdrawn CN105456533A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510993085.2A CN105456533A (en) 2015-12-28 2015-12-28 Traditional Chinese medicine formula for treating ankylosing spondylitis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510993085.2A CN105456533A (en) 2015-12-28 2015-12-28 Traditional Chinese medicine formula for treating ankylosing spondylitis

Publications (1)

Publication Number Publication Date
CN105456533A true CN105456533A (en) 2016-04-06

Family

ID=55594990

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510993085.2A Withdrawn CN105456533A (en) 2015-12-28 2015-12-28 Traditional Chinese medicine formula for treating ankylosing spondylitis

Country Status (1)

Country Link
CN (1) CN105456533A (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103071134A (en) * 2013-01-28 2013-05-01 广西玉林大金大药业有限公司 External preparation for treating rheumatic arthrodynia and traumatic pain and swelling and preparation method thereof
CN103157081A (en) * 2013-04-01 2013-06-19 程爱军 Medicament for relaxing tendons and activating collaterals
CN104524174A (en) * 2015-01-23 2015-04-22 杨睿 Traditional Chinese medicine composition for treating rheumatic arthralgia and preparation method thereof
CN104740201A (en) * 2015-04-21 2015-07-01 杜卫卫 Traditional Chinese medicine preparation for treating ankylosing spondylitis

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103071134A (en) * 2013-01-28 2013-05-01 广西玉林大金大药业有限公司 External preparation for treating rheumatic arthrodynia and traumatic pain and swelling and preparation method thereof
CN103157081A (en) * 2013-04-01 2013-06-19 程爱军 Medicament for relaxing tendons and activating collaterals
CN104524174A (en) * 2015-01-23 2015-04-22 杨睿 Traditional Chinese medicine composition for treating rheumatic arthralgia and preparation method thereof
CN104740201A (en) * 2015-04-21 2015-07-01 杜卫卫 Traditional Chinese medicine preparation for treating ankylosing spondylitis

Similar Documents

Publication Publication Date Title
CN104623167A (en) Traditional Chinese medicine plaster for treating neck-shoulder and lumbocrural pain
CN103893365B (en) A kind of JINGUTONGXIAO WAN
CN101396541B (en) Traditional Chinese medicine for treating the cervical vertebra disease
CN103933171B (en) A kind of External apply medicinal wine for the treatment of lumbago and skelalgia
CN103356953B (en) A kind of Chinese medicine composition for the treatment of lumbar muscle strain
CN102380011B (en) Traditional Chinese medicine composition for treating polyarteritis nodosa
CN108186749A (en) Treat Chinese medicine composition of cervical spondylosis and preparation method thereof
CN104523999B (en) It is a kind of for the Chinese medicine preparation of osteoporosis and its preparation method of paste
CN104042681B (en) Be used for the treatment of the external decoction of urticaria
CN103610831B (en) A kind of Chinese medicine for the treatment of neck and shoulder pain
CN105456533A (en) Traditional Chinese medicine formula for treating ankylosing spondylitis
CN102512566B (en) Chinese medicine composition for treating kidney deficiency and lumbago
CN105456673A (en) Traditional Chinese medicine composition for treating ankylosing spondylitis
CN103251901A (en) Oral traditional Chinese medicine preparation for treating dysmenorrhea
CN105477046A (en) Traditional Chinese medicine preparation for treating ankylosing spondylitis
CN102784280A (en) Traditional Chinese medicine fumigating and washing liquid for treating migraine
CN103285108B (en) Chinese medicinal composition treating lumbago
CN103099999B (en) Traditional Chinese medicine for treating gout disease
CN103157072B (en) Chinese medicinal composition for treating cervical spondylosis
CN103028080A (en) Traditional Chinese medicine decoction for treating qi-stagnancy and blood stasis prostatitis
CN102258589B (en) Deer blood medicinal wine for treating rheumatoid arthritis
CN105232744A (en) Traditional Chinese medicine composition for treating lumbago
CN106361840A (en) Traditional Chinese medicine composite used for treating rheumatism and preparing method thereof
CN105381098A (en) Traditional Chinese medicine fumigating and washing agent for treating knee osteoarthritis and nursing method
CN102188669B (en) Medicament for treating cold-dampness obstruction syndrome and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WW01 Invention patent application withdrawn after publication

Application publication date: 20160406

WW01 Invention patent application withdrawn after publication